Myocardial uptake of 99mTc-tetrofosmin, sestamibi, and 201Tl in a model of acute coronary reperfusion

Circulation

Volumn 94, Issue 10, 1996, Pages 2605-2613

  Takahashi, Norio ^a   Reinhardt, Christopher P ^a   Marcel, Robin ^a   Leppo, Jeffrey A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

coronary disease; ischemia; myocardium; nuclear medicine; radioisotopes

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MICROSPHERE TC 99M; TETROFOSMIN TC 99M; THALLIUM 201; TRACER; NITROBLUE TETRAZOLIUM; ORGANOPHOSPHORUS COMPOUND; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE; THALLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY REPERFUSION; DRUG UPTAKE; HEART INFARCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HEMODYNAMICS; HISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THORACOTOMY; TISSUE DISTRIBUTION; ANIMAL; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; HEART MUSCLE; HEART MUSCLE REPERFUSION; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; STAINING;

ANIMALS; CORONARY CIRCULATION; CORONARY DISEASE; HEMODYNAMIC PROCESSES; MALE; MYOCARDIAL REPERFUSION; MYOCARDIUM; NITROBLUE TETRAZOLIUM; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; STAINING AND LABELING; TECHNETIUM TC 99M SESTAMIBI; THALLIUM; THALLIUM RADIOISOTOPES;

EID: 0029662108     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.10.2605     Document Type: Article

References (30)

1. Pohost GM, Zir LM, Moore RH, McKusick KA, Guiney TE, Beller GA. Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201. Circulation. 1977;55:294-302.
2. Dilsizian V, Rocco TP, Freedman NMT, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med. 1990;323:141-146.
3. Gewirtz H, Beller GA, Strauss HW, Dinsmore RE, Zir LM, McKusick KA, Pohost GM Transient defects of resting thallium scans in patients with coronary artery disease. Circulation. 1979;59: 101-113.
4. Wackers FJTh, Berman DS, Maddahi J, Watson DD, Beller GA, Strauss HW, Boucher CA, Picard M. Holman BL, Fridrich R, Inglese E, Delaloye B, Bischof-Delaloye A, Camin L, McKusick K. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med. 1989;30:301-311.
5. 201Tl imaging and coronary angiography in a phase III multicenter trial. Circulation. 1995;91:313-319.
6. Maddahi J, Ganz W, Hinomiya K, Hashida J, Fishbein MC, Mondkar A, Buchbinder N, Marcus H, Geft I, Shah PK, Rozanski A, Swan HJC, Berman DS. Myocardial salvage by intracoronary thrombolysis in evolving acute myocardial infarction: evaluation using intracoronary injection of thallium-201. Am Heart J. 1981;102:664-674.
7. Schuler G, Schwartz F, Hofmann M, Mehmel H, Manthey J, Maurer W, Rauch B, Herrmann H-J, Kübler W, Thrombolysis in acute myocardial infarction using intracoronary streptokinase: assessment by thallium-201 scintigraphy. Circulation. 1982;66:658-664.
8. Pellikka PA, Behrenbeck T, Verani MS, Mahmarian JJ, Wackers FJTh, Gibbons RJ. Serial changes in myocardial perfusion using tomographic technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging following reperfusion therapy of myocardial infarction. J Nucl Med. 1990;31:1269-1275.
9. Santoro GM, Bisi G, Sciagra R, Leoncini M, Fazzini PF, Meldolesi U. Single photon emission computer tomography with technetium99m hexakis 2-methoxyisobutyl isonitrile in acute myocardial infarction before and after thrombolytic treatment: assessment of salvaged myocardium and prediction of late functional recovery. J Am Coll Cardiol. 1990;15:301-314.
10. Sridhara BS, Braat S, Rigo P, Itti R, Cload P, Lahiri A. Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease. Am J Cardiol 1993; 72:1015-1019.
11. 99mTc-tetrofosmin imaging? A quantitative study using serial planar imaging. Circulation. 1992;86(suppl I):I-46. Abstract.
12. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells: mitochondrial and plasma membrane potential dependence. Circulation. 1990;82:1826-1838.
13. Reinhardt CP, Weinstein H, Leppo JA. Comparison of iodine-125-BMIPP and thallium-201 in myocardial hypoperfusion. J Nucl Med. 1995;36:1645-1653.
14. Weinstein H, Reinhardt CP, Leppo JA. Teboroxime, sestamibi and thallium-201 as markers of myocardial hypoperfusion: comparison by quantitative dual isotope autoradiography in rabbits. J Nucl Med. 1993;34:1510-1517.
15. Reinhardt CP, Weinstein H, Wironen J, Leppo JA. Effect of triphenyl tetrazolium chloride staining on the distribution of radiolabeled pharmaceuticals. J Nucl Med. 1993;34:1722-1727.
16. Villegas BJ, Reinhardt CP, Dahlberg ST, Marcel R, Heller LI, Leppo JA. Sestamibi distribution in viable and non-viable myocardium assessed independent of the effect of vital stains. J Nucl Med. 1994; 35:152P. Abstract.
17. Heyman MA, Payne BD, Hoffman JIE, Rudolph AM. Blood flow measurement with radionuclide-labeled particles. Prog Cardiovasc Dis. 1977;20:55-79.
18. King RB, Bassingthwaighte JB, Hales JRS, Rowell LB. Stability of heterogeneity of myocardial blood flow in normal awake baboons. Circ Res. 1985;57:285-295.
19. Yipintsoi T, Dobbs WA Jr, Scanlon PD, Knopp TJ, Bassingthwaighte JB. Regional distribution of diffusible tracers and carbonized microspheres in the left ventricle of isolated dog hearts. Circ Res. 1973; 33:573-587.
20. Glover DK, Ruiz M, Sansoy V, Kryzhanovski V, Smith WH, Watson DD, Beller GA. Myocardial uptake of Tc-99m tetrofosmin in canine models of coronary occlusion and reperfusion. Circulation. 1993;88 (suppl I):I-441. Abstract.
21. Sinusas AJ, Trautman KA, Bergin JD, Watson DD, Ruiz M, Smith WH, Beller GA. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl nitrile. Circulation. 1990;82: 1424-1437.
22. Kelly JD, Forster AM, Higley B, Archer CM, Booker FS, Canning LR, Chiu KW, Edwards B, Gill HK, McPartlin M, Nagle KR, Latham IA, Pickett RD, Storey AE, Webbon PM. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med. 1993;34:222-227.
23. Platts EA, North TL, Pickett RD, Kelly JD. Mechanism of uptake of technetium-tetrofosmin, I: uptake into isolated adult rat ventricular myocytes and subcellular localization. J Nucl Cardiol. 1995;2: 317-326.
24. Younès A, Songadele A, Maublant J, Platts E, Pickett R, Veyre A. Mechanism of uptake of technetium-tetrofosmin, II: uptake into isolated adult rat heart mitochondria. J Nucl Cardiol. 1995;2:327-333.
25. 201Tl in the presence of severe coronary artery stenosis. Circulation. 1994;89:2332-2341.
26. 18F]fluorodeoxyglucose. Circulation. 1994;89:578-587.
27. 99mTc-sestamibi uptake and retention during myocardial ischemia and reperfusion. Circulation. 1993;87:2033-2042.
28. Sinusas AJ, Shi QX, Saltzberg MT, Chang PI, Vitols PJ, Jain D, Wackers FJTh, Zaret BL. Technetium-99m tetrofosrnin for assessment of myocardial perfusion: initial distribution and clearance relationship to blood flow. J Nucl Med. 1992;33:993. Abstract.
29. Dahlberg ST, Gilmore MP, Leppo JA. Effect of coronary blood flow on the 'uptake' of tetrofosmin in the isolated rabbit heart. J Nucl Med. 1992;33:846. Abstract.
30. Dahlberg ST, Gilmore MP, Flood M, Leppo JA. Extraction and washout of Tc-99m tetrofosmin in the isolated rat heart. J Nucl Med. 1994; 35:47P. Abstract.